Shobana Albrecht

Shobana Albrecht has an extensive work experience in the field of business development and corporate development. Shobana is currently a board member at LooseEnds Project, a position they have held since June 2023. Previously, they served as the Senior Director of Alliance Management & Business Development at Generate Biomedicines, Inc. starting in April 2022. Prior to that, they were the Senior Director of Business Development & Head of Alliance Management at Editas Medicine from January 2020 to April 2022. Shobana also has experience working at Thermo Fisher Scientific, where they held various roles including Senior Director of Business Development from January 2014 to December 2019. Shobana was also the VP of Corporate Development at SpringLeaf Therapeutics, Inc from March 2009 to September 2011. Before that, they worked as the Senior Director of Corporate Development at BG Medicine from June 2008 to March 2009. Shobana's career started at Baxter International in 1993, where they worked as the Director of Business Development until June 2000. Shobana then briefly served as the Chief Financial Officer at TxMS from June 2000 to June 2001. Shobana returned to Baxter International and served as the Director of Business Development from June 2001 to July 2007, during which they were responsible for the Cytotoxic Contract Services business. Overall, Shobana Albrecht has a strong background in business and corporate development, bringing valuable experience and expertise to their current and past roles.

Shobana Albrecht holds a Bachelor of Science (B.S.) degree from Carnegie Mellon University. Shobana also obtained a Master of Business Administration (MBA) degree from Carnegie Mellon University - Tepper School of Business.